1型糖尿病合并冠心病患者的骨骼肌胰岛素抵抗研究
本研究采用正常血糖胰岛素钳夹联合[18F]FDG PET显像,测量9例合并冠心病与10例未合并冠心病的1型糖尿病参与者的腓肠肌和胫骨前肌胰岛素抵抗。结果显示1型糖尿病整体存在全身及骨骼肌胰岛素抵抗,但合并冠心病者并不更严重;胫骨前肌FDG摄取与冠脉钙化严重程度正相关,且在合并冠心病者中增加75%。
要点
- 1型糖尿病存在全身及骨骼肌胰岛素抵抗,但合并冠心病并未使其更严重
- 腓肠肌胰岛素抵抗在合并与未合并冠心病者中程度相当
- 胫骨前肌FDG摄取与冠脉钙化严重程度正相关,合并冠心病者增加75%
核心结论
- 1型糖尿病存在全身和骨骼肌特异性胰岛素抵抗,但在合并冠心病时并不更严重。
- 腓肠肌与胫骨前肌在1型糖尿病中表现明显不同:腓肠肌明确存在胰岛素抵抗且合并与未合并冠心病者程度相当,而胫骨前肌未提示胰岛素抵抗。
研究设计与样本
- 研究纳入1型糖尿病合并冠心病者9例(CAD+)与未合并冠心病者10例(CAD-),采用正常血糖胰岛素输注联合[18F]FDG PET显像测量腓肠肌与胫骨前肌的葡萄糖摄取。
- 冠脉钙化(CAC)评分采用电子束断层扫描定量,并与历史非糖尿病参与者13例进行比较。
主要发现
- CAD+组1型糖尿病参与者的CAC评分较CAD-组高100倍以上,但两组HbA1c与胰岛素剂量无差异。
- 钳夹研究中CAD+与CAD-组葡萄糖处置相似,但均较历史非糖尿病参与者存在胰岛素抵抗。
- 腓肠肌FDG摄取在合并与未合并冠心病的1型糖尿病参与者中总体相似降低(较非糖尿病者)。
- CAD-组1型糖尿病参与者胫骨前肌FDG摄取未降低,而CAD+组增加75%(p < 0.01)。
- 全部1型糖尿病参与者中,胫骨前肌FDG摄取与CAC严重程度呈正相关。
关键数值与推荐
- CAD+组CAC评分较CAD-组高100倍以上。
- CAD+组胫骨前肌FDG摄取较CAD-组增加75%(p < 0.01)。
- CAD+与CAD-组HbA1c及胰岛素剂量无差异。
临床怎么用
- 1型糖尿病合并冠心病者骨骼肌胰岛素抵抗并不更严重,提示冠心病风险可能不完全由胰岛素抵抗介导。
- 不同骨骼肌类型(腓肠肌与胫骨前肌)的胰岛素抵抗表现存在差异,评估时需考虑肌肉特异性。
局限性
- 样本量小(CAD+组9例、CAD-组10例),结论需更大样本验证。
- 非糖尿病对照为历史数据(13例),非同期对照。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The risk for coronary artery disease (CAD) is substantially increased in type 1 diabetes and it has been postulated that insulin resistance may contribute to this risk. The current study measured insulin resistance in type 1 diabetes with vs without CAD and with a focus upon skeletal muscle, to test the hypothesis that insulin resistance is more severe in participants who have type 1 diabetes and CAD. Additionally, in type 1 diabetes, we examined the hypothesis that insulin resistance is more severe in soleus (an oxidative type muscle) vs tibialis anterior (a more glycolytic type of muscle). METHODS: Insulin resistance was measured in participants with type 1 diabetes with (n = 9, CAD+) and without CAD (n = 10, CAD-) using euglycaemic insulin infusions combined with positron emission tomography (PET) imaging of [18F]fluorodeoxyglucose (FDG) uptake into soleus and tibialis anterior skeletal muscles. Coronary artery calcium (CAC) score was quantified by electron beam tomography. RESULTS: CAD+ participants with type 1 diabetes had a >100-fold higher CAC score than did CAD- participants with type 1 diabetes but groups did not differ in HbA1c or insulin dose. During clamp studies, CAD+ and CAD- groups had similar glucose disposal but were insulin resistant compared with historical non-diabetic participants (n = 13). FDG uptake by soleus muscle was similarly reduced, overall, in individuals with type 1 diabetes with or without CAD compared with non-diabetic individuals. However, FDG uptake by tibialis anterior muscle was not reduced in CAD- participants with type 1 diabetes while in CAD+ participants with type 1 diabetes it was 75% greater (p < 0.01). Across all participants with type 1 diabetes, FDG uptake by tibialis anterior muscle correlated positively with CAC severity. CONCLUSIONS/INTERPRETATION: Our study confirms that systemic and skeletal muscle-specific insulin resistance is seen in type 1 diabetes but found that it does not appear to be more severe in the presence of CAD. There were, however, sharp differences between soleus and tibialis anterior muscles in type 1 diabetes: while insulin resistance was clearly manifest in soleus muscle, and was of equal severity in CAD+ and CAD- participants, tibialis anterior did not suggest insulin resistance in participants with type 1 diabetes, as FDG uptake by tibialis anterior correlated positively with CAC severity and was significantly increased in participants with type 1 diabetes and clinical CAD. Graphical abstract.
引用
- Williams KV, Shay CM, Price JC, et al. Muscle insulin resistance in type 1 diabetes with coronary artery disease. Diabetologia. 2020. PMID: 32926189. doi:10.1007/s00125-020-05270-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。